Congenital Hematological Disorder Completed Phase 1 Trials for Antihemophilic factor, human recombinant (DB00025)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00837356Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A SubjectsTreatment